Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11033588
Compositions for treating inflammation and uses thereof
granted patentUS 11033640
Enteric CT contrast material based on low-z atoms
granted patentUS 11034933
Methods for selectively expanding and enriching cells transduced with chimeric antigen rec
granted patentUS 11033605
Methods of promoting angiogenesis in tissue with fibromodulin
granted patentUS 11028412
Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod
granted patentUS 11028362
Decellularized human amniotic membrane for cell delivery, cell culture and inflammation pr
granted patentUS 11028129
Compositions for expanding regulatory T cells (Treg) populations, and treating and amelior
granted patentUS 11028128
Inhibition of the aggregation of transthyretin by specific binding of peptides to aggregat
granted patentUS 11028162
Methods for manufacturing activatable binding polypeptides comprising matrix metalloprotea
granted patentUS 11021506
Thiosaccharide mucolytic agents
granted patentUS 11021517
Optimized peptides for targeting human nerves and their use in image guided surgery, diagn
granted patentUS 11021497
Compositions and methods for synthesis of phosphorylated molecules
granted patentUS 11021523
Cyanobacteriochromes active in the far-red to near-infrared
granted patentUS 11020488
Pyrroloquinolin compounds and methods of using same
granted patentUS 11021545
Multimodal cancer therapy comprising chimeric viral/nonviral nanoparticles and anticancer
granted patentUS 11020463
Method of determining cellular protein homeostasis
granted patentUS 11020345
Nanostraw devices and methods of fabricating and using the same
granted patentUS 11020409
Broad antiviral therapy with membrane modifying oxysterols
granted patentUS 11013705
Methods and compositions for supporting renal health
granted patentUS 11014950
Nucleotide analogs
granted patentUS 11014955
Cyclic peroxides as prodrugs for selective delivery of agents
granted patentUS 11014980
Transforming growth factor-beta-responsive polypeptides and their methods for use
granted patentUS 11016093
Disease-associated antigens and methods of use thereof
granted patentUS 11007281
Nano/micromotors for active and dynamic intracellular payload delivery
granted